Nuvectra (NVTR) Return on Equity ROE from the second quarter 2019 to second quarter 2018 and annually, average high and low, overall ranking from Jun 30 2019 to Jun 30 2018 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Nuvectra Corp  (NVTR)

Nuvectra's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Nuvectra in the second quarter 2019?
Nuvectra Corp recorded a cumulative net loss of $-52 million during 12 months ending in the second quarter 2019, resulting in a negative return on equity (ROE) of -59.77%.

Within the Medical Equipment & Supplies industry 105 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the first quarter 2019 from 0 to 3626.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter		 (Jun 30 2018)
II. Quarter
Y / Y Equity Change 34.77 % 27.24 % 92.84 % 85.92 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -52 -52 -48 -44 -43
Return On Equity (TTM) -59.77 % -63.81 % -61.85 % -65.85 % -77.95 %
NVTR's Total Ranking # 3626 # 0 # 0 # 0 # 0
Equity (TTM) in Millions 70 80 93 104 52
Seq. Equity Change -12.58 % -14.36 % -10.88 % 101.99 % -17.47 %
Seq. Net Income Change - - - - -

Back to NVTR Management Effectiveness >> NVTR's 5 Years Annual ROE >> Compare NVTR ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 106
Sector # 408
Overall # 3626

Return On Equity Statistics
High Average Low
-36.84 %
-59.89 %
-77.65 %
(Dec 30 2016)   (Jun 30 2018)





NVTR Annual Return On Equity (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 30 2016)
2016

Total Equity in Millions 93 48 89 0 0
Y / Y Equity Change 92.84 % -45.62 % - - -
Net Income in Millions -48 -45 -38 0 0
Y / Y Net Income Change - - - - -
Return On Equity -51.81 % -92.58 % -43.38 % - -

Back to NVTR Management Effectiveness >> NVTR's 5 Years Annual ROE >> Compare NVTR ROE to its Competitors




More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
NVTR's' Return on Equity at Yahoo Finance
NVTR's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for NVTR's Competitors
Subscribers only: Roe for Nuvectra's Suppliers
Subscribers only: Return On Equity for NVTR's Customers




Companies with similar Return On Equity at Jun 30 2019, within Healthcare Sector ROE

Date modified: 2026-09-08T15:09:36+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.